share_log

Expert Ratings for Aveanna Healthcare Hldgs

Benzinga Real-time News ·  Aug 19, 2022 10:08

Over the past 3 months, 4 analysts have published their opinion on Aveanna Healthcare Hldgs (NASDAQ:AVAH) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish
Total Ratings 1 1 2 0 0
Last 30D 0 1 0 0 0
1M Ago 1 0 1 0 0
2M Ago 0 0 1 0 0
3M Ago 0 0 0 0 0

In the last 3 months, 4 analysts have offered 12-month price targets for Aveanna Healthcare Hldgs. The company has an average price target of $4.25 with a high of $6.00 and a low of $2.50.

Below is a summary of how these 4 analysts rated Aveanna Healthcare Hldgs over the past 3 months. The greater the number of bullish ratings, the more positive analysts are on the stock and the greater the number of bearish ratings, the more negative analysts are on the stock

This current average has decreased by 42.41% from the previous average price target of $7.38.

If you are interested in following small-cap stock news and performance you can start by tracking it here.

Analyst Ratings: What Are They?

Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.

Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment